BioAtla Inc

NASDAQ:BCAB  
34.66
-2.01 (-5.48%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.17B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.98 Million
Adjusted EPS-$0.64
See more estimates
10-Day MA$37.41
50-Day MA$40.04
200-Day MAN/A
See more pivots

BioAtla Inc Stock, NASDAQ:BCAB

11085 Torreyana Road, San Diego, California 92121
United States of America
Phone: +1.858.558.0708
Number of Employees:

Description

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.